Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update Summary

被引：9
作者：
Van Poznak, Catherine
Somerfield, Mark R. [1 ]
Moy, Beverly
机构：
[1] Amer Soc Clin Oncol, 2318 Mill Rd,Suite 800, Alexandria, VA 22314 USA
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2017年 / 13卷 / 12期
关键词：
ZOLEDRONIC ACID; TRIAL;
D O I：
10.1200/JOP.2017.027672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：822 / +
页数：4
相关论文
共 6 条
[1]   Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial [J].
Amadori, Dino ;
Aglietta, Massimo ;
Alessi, Barbara ;
Gianni, Lorenzo ;
Ibrahim, Toni ;
Farina, Gabriella ;
Gaion, Fernando ;
Bertoldo, Francesco ;
Santini, Daniele ;
Rondena, Roberta ;
Bogani, Paola ;
Ripamonti, Carla I. .
LANCET ONCOLOGY, 2013, 14 (07) :663-670
[2]   American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer [J].
Hillner, BE ;
Ingle, JN ;
Berenson, JR ;
Janjan, NA ;
Albain, KS ;
Lipton, A ;
Yee, G ;
Biermann, JS ;
Chlebowski, RT ;
Pfister, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) :1378-1391
[3]  
HILLNER BE, 2004, J CLIN ONCOL, V22, P1351
[4]   Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases A Randomized Clinical Trial [J].
Himelstein, Andrew L. ;
Foster, Jared C. ;
Khatcheressian, James L. ;
Roberts, John D. ;
Seisler, Drew K. ;
Novotny, Paul J. ;
Qin, Rui ;
Go, Ronald S. ;
Grubbs, Stephen S. ;
O'Connor, Tracey ;
Velasco, Mario R., Jr. ;
Weckstein, Douglas ;
O'Mara, Ann ;
Loprinzi, Charles L. ;
Shapiro, Charles L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (01) :48-58
[5]   Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4Weeks inWomen With Breast Cancer Metastatic to Bone The OPTIMIZE-2 Randomized Clinical Trial [J].
Hortobagyi, Gabriel N. ;
Van Poznak, Catherine ;
Harker, W. Graydon ;
Gradishar, William J. ;
Chew, Helen ;
Dakhil, Shaker R. ;
Haley, Barbara B. ;
Sauter, Nicholas ;
Mohanlal, Ramon ;
Zheng, Ming ;
Lipton, Allan .
JAMA ONCOLOGY, 2017, 3 (07) :906-912
[6]   American Society of Clinical Oncology Clinical Practice Guideline Update: Recommendations on the Role of Bone-Modifying Agents in Metastatic Breast Cancer [J].
Van Poznak, Catherine H. ;
Von Roenn, Jamie H. ;
Temin, Sarah .
JOURNAL OF ONCOLOGY PRACTICE, 2011, 7 (02) :117-121
1